Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001477932-19-005477
Filing Date
2019-09-20
Accepted
2019-09-20 16:35:26
Documents
1

Document Format Files

Seq Description Document Type Size
1 POS AM ipix_posam.htm POS AM 168186
  Complete submission text file 0001477932-19-005477.txt   169368
Mailing Address 100 CUMMING CENTER SUITE 151-B BEVERLY MA 01915
Business Address 100 CUMMING CENTER SUITE 151-B BEVERLY MA 01915 978-921-4125
Innovation Pharmaceuticals Inc. (Filer) CIK: 0001355250 (see all company filings)

EIN.: 134303398 | State of Incorp.: NV | Fiscal Year End: 0630
Type: POS AM | Act: 33 | File No.: 333-220419 | Film No.: 191105113
SIC: 2834 Pharmaceutical Preparations